Next Article in Journal
Ionic Liquids as Advanced Lubricant Fluids
Next Article in Special Issue
Plant-Derived Antimalarial Agents: New Leads and Efficient Phytomedicines. Part II. Non-Alkaloidal Natural Products
Previous Article in Journal
A New Sesquiterpene from the Fruits of Daucus carota L.
Previous Article in Special Issue
Pentavalent Antimonials: New Perspectives for Old Drugs
Article Menu

Export Article

Open AccessReview
Molecules 2009, 14(8), 2868-2887; doi:10.3390/molecules14082868

Recent Advances in the Discovery of Haem-Targeting Drugs for Malaria and Schistosomiasis

University of Stellenbosch, Private Bag X1, Matieland 7602, South Africa
University of Cape Town, Private Bag, Rondebosch 7701, South Africa
Author to whom correspondence should be addressed.
Received: 30 June 2009 / Revised: 20 July 2009 / Accepted: 22 July 2009 / Published: 4 August 2009
(This article belongs to the Special Issue Neglected Diseases: Medicinal Chemistry and Natural Product Chemistry)
View Full-Text   |   Download PDF [824 KB, uploaded 18 June 2014]   |  


Haem is believed to be the target of some of the historically most important antimalarial drugs, most notably chloroquine. This target is almost ideal as haem is host-derived and the process targeted, haemozoin formation, is a physico-chemical process with no equivalent in the host. The result is that the target remains viable despite resistance to current drugs, which arises from mutations in parasite membrane transport proteins. Recent advances in high-throughput screening methods, together with a better understanding of the interaction of existing drugs with this target, have created new prospects for discovering novel haem-targeting chemotypes and for target-based structural design of new drugs. Finally, the discovery that Schistosoma mansoni also produces haemozoin suggests that new drugs of this type may be chemotherapeutic not only for malaria, but also for schistosomiasis. These recent developments in the literature are reviewed.
Keywords: haem; haemozoin; high-throughput screening; rational drug design haem; haemozoin; high-throughput screening; rational drug design

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

De Villiers, K.A.; Egan, T.J. Recent Advances in the Discovery of Haem-Targeting Drugs for Malaria and Schistosomiasis. Molecules 2009, 14, 2868-2887.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top